Detalles de la búsqueda
1.
Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
J Cell Biochem
; 122(8): 835-850, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33876843
2.
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways.
Anticancer Drugs
; 31(8): 759-775, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32796402
3.
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
Front Immunol
; 14: 1244159, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37901240
4.
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
Front Immunol
; 13: 987298, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36090975
5.
Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling.
Biomolecules
; 11(2)2021 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33572742
6.
Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer.
Transl Oncol
; 14(6): 101046, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761370
7.
Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.
PLoS One
; 16(4): e0251106, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914835
8.
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.
PLoS One
; 15(10): e0226464, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33035223
9.
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer.
Front Oncol
; 10: 1164, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32850332
10.
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Front Immunol
; 9: 1288, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29915603
11.
Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways.
Front Oncol
; 8: 575, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30564555
12.
Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo.
Anticancer Agents Med Chem
; 13(4): 595-602, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23272972
13.
Elevated expression of IRS2 in the progression from neurofibroma to malignant peripheral nerve sheath tumor.
Anticancer Res
; 32(2): 439-43, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22287730
14.
Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth.
Cell Cycle
; 11(17): 3250-9, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22894899
15.
Focal adhesion kinase signaling and function in pancreatic cancer.
Front Biosci (Elite Ed)
; 3(2): 750-6, 2011 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21196348
16.
A novel small molecule inhibitor of FAK and IGF-1R protein interactions decreases growth of human esophageal carcinoma.
Anticancer Agents Med Chem
; 11(7): 629-37, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21707510
17.
FAK and interacting proteins as therapeutic targets in pancreatic cancer.
Anticancer Agents Med Chem
; 10(10): 742-6, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21235432
18.
Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.
Epilepsia
; 48(6): 1143-50, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17484755
Resultados
1 -
18
de 18
1
Próxima >
>>